These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 19692432

  • 1. Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?
    Podbielska M, Hogan EL.
    Mult Scler; 2009 Sep; 15(9):1011-29. PubMed ID: 19692432
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serological reactions against glycolipid-sensitised liposomes in multiple sclerosis.
    Hirsch HE, Parks ME.
    Nature; 2009 Sep; 264(5588):785-7. PubMed ID: 1012320
    [No Abstract] [Full Text] [Related]

  • 6. Myelin peptides in multiple sclerosis.
    Grau-López L, Raïch D, Ramo-Tello C, Naranjo-Gómez M, Dàvalos A, Pujol-Borrell R, Borràs FE, Martínez-Cáceres E.
    Autoimmun Rev; 2009 Jul; 8(8):650-3. PubMed ID: 19393199
    [Abstract] [Full Text] [Related]

  • 7. The structure and function of central nervous system myelin.
    Williams KA, Deber CM.
    Crit Rev Clin Lab Sci; 1993 Jul; 30(1):29-64. PubMed ID: 7683887
    [Abstract] [Full Text] [Related]

  • 8. DNA-based vaccines: the future of multiple sclerosis therapy?
    Stüve O, Cravens PD, Eagar TN.
    Expert Rev Neurother; 2008 Mar; 8(3):351-60. PubMed ID: 18345967
    [Abstract] [Full Text] [Related]

  • 9. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S.
    Neurology; 2007 May 29; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [Abstract] [Full Text] [Related]

  • 10. Immunobiology of oligodendrocytes in multiple sclerosis.
    Ruffini F, Chojnacki A, Weiss S, Antel JP.
    Adv Neurol; 2006 May 29; 98():47-63. PubMed ID: 16400826
    [No Abstract] [Full Text] [Related]

  • 11. Activation of myelin reactive T cells in multiple sclerosis: a possible role for T cell degeneracy?
    Stinissen P, Hellings N.
    Eur J Immunol; 2008 May 29; 38(5):1190-3. PubMed ID: 18425726
    [Abstract] [Full Text] [Related]

  • 12. Structure and function of the myelin proteins: current status and perspectives in relation to multiple sclerosis.
    Tzakos AG, Troganis A, Theodorou V, Tselios T, Svarnas C, Matsoukas J, Apostolopoulos V, Gerothanassis IP.
    Curr Med Chem; 2005 May 29; 12(13):1569-87. PubMed ID: 15974988
    [Abstract] [Full Text] [Related]

  • 13. Lipid autoreactivity in multiple sclerosis.
    Blewett MM.
    Med Hypotheses; 2010 Mar 29; 74(3):433-42. PubMed ID: 19932569
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of oligoclonal IgM specificity in multiple sclerosis disease course.
    Villar L, García-Barragán N, Espiño M, Roldán E, Sádaba M, Gómez-Rial J, González-Porqué P, Alvarez-Cermeño J.
    Mult Scler; 2008 Mar 29; 14(2):183-7. PubMed ID: 17942517
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis.
    Taoufik E, Tseveleki V, Euagelidou M, Emmanouil M, Voulgari-Kokota A, Haralambous S, Probert L.
    Neurodegener Dis; 2008 Mar 29; 5(1):32-7. PubMed ID: 18075273
    [Abstract] [Full Text] [Related]

  • 18. Mini review: immune response to myelin-derived sulfatide and CNS-demyelination.
    Halder RC, Jahng A, Maricic I, Kumar V.
    Neurochem Res; 2007 Feb 29; 32(2):257-62. PubMed ID: 17006761
    [Abstract] [Full Text] [Related]

  • 19. Myelin-basic protein-reactive specific CD4+ and CD8+ NK lymphocytes induce morphological changes in neuronal cell bodies and myelin sheaths: implications for multiple sclerosis.
    Zhang QY, Huang JH, Li HZ, Guo HT, Zhong YQ, Wang YM, Pei JM.
    Arch Med Res; 2008 Jan 29; 39(1):45-51. PubMed ID: 18067995
    [Abstract] [Full Text] [Related]

  • 20. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies.
    von Büdingen HC, Harrer MD, Kuenzle S, Meier M, Goebels N.
    Eur J Immunol; 2008 Jul 29; 38(7):2014-23. PubMed ID: 18521957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.